Apollo Hospitals Enterprise share news, announcements and annual reports
NSE: APOLLOHOSPBSE: 508869Healthcare ServicesLarge Cap
Apollo Hospitals Enterprise Limited · Face value ₹5 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Mar 1983 on BSE, Jan 1996 on NSE
Last close ₹8,448.00up ₹248.00 (3.02%)BSE ₹8,400.00
Share price at the NSE close on 30 Oct 2026. Previous close ₹8,200.00.
30 Oct: open ₹8,195.00, high ₹8,448.00, low ₹8,176.00
52-week range of traded prices to 30 Oct 2026
₹6,696.50Low, 23 Jan 2026₹9,070.50High, 23 Sep 2026
- Next results date: the board meets on 4 Nov 2026 to consider: financial results and other business matters. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,21,469 Cr97th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 58.13
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 12.81
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.24%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 23.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 19.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.57
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 3,72,15658.2% delivered
Apollo Hospitals Enterprise share news and announcements
863 announcements, routine notices left out, newest first. Page 16 of 18.
Jan 2011
24 Jan · Board meeting
Inter alia, to consider, approve and take on record unaudited financial results of the Company for the quarter / nine months ended December 31, 2010.
Dec 2010
7 Dec · Board meeting
To consider allotment of 1,140,992 equity shares to the International Finance Corporation, Washington DC at a price of Rs. 302.50 per equity share of Rs. 5/- each upon part conversion of FCCB loan amount of USD 7.5 million.
Nov 2010
9 Nov · Results
Standalone Results for the quarter ended on 30-SEP-2010 as follows: Net Sales of Rs. 58640 lacs for quarter ending on 30-SEP-2010 against Rs. 45606 lacs for the quarter ending on 30-SEP-2009. Net Profit / (Loss) of Rs. 4955 lacs for the quarter ending on 30-SEP-2010 against Rs. 3406 lacs for the quarter ending on 30-SEP-2009.
Oct 2010
20 Oct · Board meeting
Inter alia, to consider, approve and take on record unaudited financial results of the Company for the quarter / half year ended September 30, 2010.
Aug 2010
12 Aug · Corporate action
Board of Directors at its meeting held on August 12, 2010 has fixed September 03, 2010 as the Record Date, for determining the eligible shareholders to receive 2 sub-divided equity shares of face value of Rs.5/- each in the place of each existing equity shares of face value of Rs.10/- each.12 Aug · Results
Standalone Results for the quarter ended on 30-JUN-2010 as follows: Net Sales of Rs. 52329 lacs for quarter ending on 30-JUN-2010 against Rs. 40595 lacs for the quarter ending on 30-JUN-2009. Net Profit / (Loss) of Rs. 3927 lacs for the quarter ending on 30-JUN-2010 against Rs. 4480 lacs for the quarter ending on 30-JUN-2009.
Jul 2010
28 Jul · Board meeting
Inter alia, to consider, approve and take on record the unaudited financial results of the Company for the quarter ended June 30, 2010.
Jun 2010
14 Jun · Business
Committee of Board of Directors at its meeting held on June 12, 2010 approved the allotment of 1,544,621 Warrants convertible into equity shares to Dr. Prathap C Reddy, with each warrant convertible into one equity share of the Company of nominal value of Rs.10/- each at a price of Rs.771.76 which includes a premium of Rs.761.75 per share. The warrants shall be convertible into equity shares at any time within 18 months from the date of allotment.10 Jun · Board meeting
Committee is meeting on June 12, 2010 to consider and approve the allotment of 1,544,621 warrants convertible into equity shares to Dr. Prathap C Reddy pursuant to the special resolution approved by the members at the EGM held on May 29, 2010.
May 2010
28 May · Meeting
Register of Members and Share Transfer Registers shall remain closed from July 17, 2010, to July 26, 2010, (both days inclusive) for the purpose of determining the names of the shareholders who are entitled for the dividend and also for the purpose of Annual General Meeting to be held on July 26, 2010.28 May · Share Split
Board of Directors of the Company, at their meeting held on May 28, 2010, approved the sub-division of each existing equity share of nominal value of Rs.10/- each into 2 (Two) equity shares of nominal value of Rs.5/- each subject to approval of members.28 May · Dividend
Board of Directors of the Company, at their meeting held on May 28, 2010, recommended a dividend of Rs.7.00 per share (70%) on the equity capital of the Company of Rs.617,848,590/- consisting of 61,784,859 equity shares of Rs.10/- each.28 May · Results
Standalone Results for the year ended on 31-MAR-2010 as follows: Net Sales of Rs. 182578 lacs for year ending on 31-MAR-2010 against Rs. 145798 lacs for the year ending on 31-MAR-2009. Net Profit / (Loss) of Rs. 15197 lacs for the year ending on 31-MAR-2010 against Rs. 11807 lacs for the year ending on 31-MAR-2009.28 May · Results
Standalone Results for the quarter ended on 31-MAR-2010 as follows: Net Sales of Rs. 48290 lacs for quarter ending on 31-MAR-2010 against Rs. 39108 lacs for the quarter ending on 31-MAR-2009. Net Profit / (Loss) of Rs. 2920 lacs for the quarter ending on 31-MAR-2010 against Rs. 2914 lacs for the quarter ending on 31-MAR-2009.12 May · Board meeting
To consider inter alia:- (1)The Audited Financial Results of the Company for the year ended March 31, 2010. (2) The Audited Consolidated Financial Results of the Company and its subsidiaries, Joint Ventures and Associate Companies for the year ended March 31, 2010. (3) To recommend a dividend, if any, for the financial year ended March 31, 2010.
Apr 2010
30 Apr · Meeting
1)The Board of Directors of the Company at its meeting held on April 30, 2010 approved, subject to shareholders approvals and necessary regulatory approvals, to issue up to 1,544,621 warrants (being 2.5% of existing paid up equity capital of the company) convertible into equity shares to Dr. Prathap C Reddy, promoter of the Company, with each warrant convertible into one equity share of the Company of nominal value of Rs.10/- each at a price of Rs. 771.76 which includes a premium of Rs. 761.76 per share, which price is not less than the price calculated in accordance with the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2009 for preferential allotment of equity shares/ warrants. An Extraordinary General Meeting of the Company is to be convened on May 29, 2010 for obtaining members approval for the above said issue. 2) Mr. S. K. Venkataraman has resigned from the post of Company Secretary and Compliance Officer of the Company and he is discharged from the duties of Company Secretary with effect from April 30, 2010. Mr. S. M. Krishnan has been appointed as Company Secretary and Compliance Officer of the Company with effect from April 30, 2010.15 Apr · Results
Company has opted to submit the Audited Financial Results for the year ended March 31, 2010 within the time limit of sixty days from the end of the financial year i.e., on or before May 30, 2010. In view of this, the Company does not propose to publish the unaudited financial results for the last quarter ended March 31, 2010.
Feb 2010
15 Feb · Updates
Notice under Section 302 of the Companies Act, 1956, being sent to the Shareholders of the Company in respect of appointment of Ms. Shobana Kamineni as Whole Time Director of the Company designated as Executive Director - Special Initiatives. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2010
28 Jan · Board meeting
Board of Directors at its meeting held on January 28, 2010 has taken the following decisions. (1) Approved the appointment of Ms. Shobana Kamineni as an Additional Director and Whole Time Director designated as Executive Director of the Company with effect from February 01, 2010, subject to approval of members. (2) Approved the allotment of 1500 Unsecured Foreign Currency Convertible Bonds (FCCB) of face value of USD 10,000 each aggregating to US$ 15,000,000 with an option of convertible into equity shares at a price of Rs.605/- per share. The Board took on record the ill health of Mr. P. Obul Reddy and consequently his inability to continue as a Director.28 Jan · Results
Standalone Results for the quarter ended on 31-DEC-2009 as follows: Net Sales of Rs. 48087 lacs for quarter ending on 31-DEC-2009 against Rs. 37300 lacs for the quarter ending on 31-DEC-2008. Net Profit / (Loss) of Rs. 4391 lacs for the quarter ending on 31-DEC-2009 against Rs. 2953 lacs for the quarter ending on 31-DEC-2008.12 Jan · Board meeting
Inter alia, to consider, approve and take on record unaudited financial results of the Company for the quarter / nine months ended December 31, 2009.
Nov 2009
11 Nov · Updates
IER (Independent Equity Research) wing of CRISL has assigned to the Company a fundamental grade of 4/5, indicating a superior rating. (Assessment - 10 to 25% upside from Current Market Price) A copy of IER Report by CRISIL on the Company shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Oct 2009
29 Oct · Management
Board of Directors at its meeting held on October 29, 2009 has taken the following decisions : 1) Approved the resignation of Mr. Neeraj Bharadwaj as a Director (Nominee of Apax Mauritius FDI One Limited) of the Company. 2) Approved the appointment of Mr. Sandeep Naik as a director (Nominee of Apax Mauritius FDI One Limited) of the Company.29 Oct · Results
Standalone Results for the quarter ended on 30-SEP-2009 as follows: Net Sales of Rs. 45606 lacs for quarter ending on 30-SEP-2009 against Rs. 36483 lacs for the quarter ending on 30-SEP-2008. Net Profit / (Loss) of Rs. 3406 lacs for the quarter ending on 30-SEP-2009 against Rs. 3013 lacs for the quarter ending on 30-SEP-2008.29 Oct · Results
Standalone Results for the half year ended on 30-SEP-2009 as follows: Net Sales of Rs. 86201 lacs for half year ending on 30-SEP-2009 against Rs. 69390 lacs for the half year ending on 30-SEP-2008. Net Profit / (Loss) of Rs. 7886 lacs for the half year ending on 30-SEP-2009 against Rs. 5940 lacs for the half year ending on 30-SEP-2008.14 Oct · Board meeting
Inter alia, to consider, approve the unaudited financial results of the Company for the quarter / half year ended September 30, 2009.
Sep 2009
1 Sep · Meeting
Minutes of the Annual General Meeting of the Company held on August 26, 2009. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2009
18 Jul · Results
Standalone Results for the quarter ended on 30-JUN-2009 as follows: Net Sales of Rs. 40595 lacs for quarter ending on 30-JUN-2009 against Rs. 32907 lacs for the quarter ending on 30-JUN-2008. Net Profit / (Loss) of Rs. 4480 lacs for the quarter ending on 30-JUN-2009 against Rs. 2927 lacs for the quarter ending on 30-JUN-2008.7 Jul · Board meeting
Meeting on 18 Jul 2009: “Unaudited Financial Results for the Qtr ended June 30, 2009”
Jun 2009
29 Jun · Meeting
Board of Directors at is meeting held on June 29, 2009 has taken the following decisions: 1) The register of members and share transfer registers shall remain closed from August 22, 2009 to August 26, 2009 (both days inclusive) for the purpose of determining the names of the shareholders who are entitled for payment of dividend and also for the purpose of Annual General Meeting. 2) The Annual General Meeting of the Company is scheduled to be held on August 26, 2009.29 Jun · Issue of FCCB/Others
Board of Directors at its meeting held on June 29, 2009 has taken the following decisions: 1) To issue Foreign Currency Convertible Bonds (FCCBs), subject to required approvals being obtained, including approval of the members of the company, for a value up to USD 15,000,000 to International Finance Corporation ("IFC"), Washington. 2) Raising of loan in Foreign Currency in the form of External Commercial Borrowing (ECB) of USD 35 millions from International Finance Corporation (IFC), subject to required approvals being obtained.29 Jun · Dividend
Board of Directors at its meeting held on June 29, 2009 has taken the following decision: Recommended a dividend of Rs. 6.50 per share on the enlarged equity capital of the Company of Rs.617,848,590 consisting of 61,784,859 equity shares of Rs.10/- each.29 Jun · Dividend
Board of Directors at its meeting held on June 29, 2009 has recommended a dividend of Rs. 6.50 per share on the enlarged equity capital of the Company of Rs.617,848,590 consisting of 61,784,859 equity shares of Rs. 10 each.29 Jun · Results
Standalone Results for the quarter ended on 31-MAR-2009 as follows: Net Sales of Rs. 39108 lacs for quarter ending on 31-MAR-2009 against Rs. 30400 lacs for the quarter ending on 31-MAR-2008. Net Profit / (Loss) of Rs. 2914 lacs for the quarter ending on 31-MAR-2009 against Rs. 2190 lacs for the quarter ending on 31-MAR-2008.29 Jun · Results
Standalone Results for the year ended on 31-MAR-2009 as follows: Net Sales of Rs. 145798 lacs for year ending on 31-MAR-2009 against Rs. 112380 lacs for the year ending on 31-MAR-2008. Net Profit / (Loss) of Rs. 11807 lacs for the year ending on 31-MAR-2009 against Rs. 10180 lacs for the year ending on 31-MAR-2008.29 Jun · Results
Consolidated Results for the year ended on 31-MAR-2009 as follows: Net Sales of Rs. 161420 lacs for year ending on 31-MAR-2009 against Rs. 121470 lacs for the year ending on 31-MAR-2008. Net Profit / (Loss) of Rs. 10249 lacs for the year ending on 31-MAR-2009 against Rs. 7710 lacs for the year ending on 31-MAR-2008.19 Jun · Board meeting
To consider inter alia:- (i) the Audited Financial Results of the Company for the year ended March 31, 2009. (ii) the Audited Consolidated Financial Results of the Company and its subsidiaries, Joint Ventures and Associate Companies for the year ended March 31, 2009. (iii) to recommend a dividend, if any, for the financial year ended March 31, 2009.
May 2009
21 May · Updates
We have received a Show Cause notice from Directorate of Enforcement, wherein we have been asked to explain the end uses of GDR issue made by the Company during the year 2005. We have received the notice on 20th May 2009 and have 30 days time to reply. We have used the proceeds for expansion of our hospital projects including investments in Bangalore & Kakinada primarily and are going into the merits of the case and will be acting as per legal advice. As far as our understanding goes, we are not in contravention of any provision of law and we feel that the issue may have been a subject matter of interpretation, which we will be addressing in due course
Apr 2009
20 Apr · Board meeting
Committee of Board of Directors at its meeting held on April 18, 2009 approved the allotment of 1,549,157 equity shares of face value of Rs. 10/- each at a price of Rs. 497.69 per share to Dr. Prathap C Reddy, promoter of the Company. Consequent to the above allotment, the paid up share capital of the company has been increased to Rs. 617,848,590/- (consisting of 61,784,859 equity shares of Rs.10/- each) from Rs. 602,357,020/- (consisting of 60,235,702 equity shares of Rs.10/- each).